Early evaluation of liposomal daunorubicin (DaunoXome, Nexstar) in the treatment of relapsed and refractory lymphoma.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/B5DF0991.svg?ark=w1%2F20260515%2FB5DF0991)](https://nobleid.org/work/w1/20260515/B5DF0991)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors